Alcohol

Cardiovascular·MeSH: Cardiovascular Diseases

65 drugs in development·45 companies·1 clinical trial

Drug Pipeline by Phase

Approved(6)

Drug	Company
acamprosate	Mylan II B.V. (MYL)
aveed	Endo LP (NDOI)
naltrexone	SUNSET ISLAND GROUP (SUN)
orbera	Apollo Endosurgery, Inc. (APEN)
testosterone	Amneal Pharmaceuticals, Inc. (AMRX)
VIVITROL	Alkermes plc. (ALKS)

Phase 3(11)

Drug	Company
100 mg resmetirom	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
AD04	ADIAL PHARMACEUTICALS, INC. (ADIL)
cenicriviroc	Allergan plc (AGN)
Efruxifermin	Keros Therapeutics, Inc. (KROS)
efruxifermin (EFX)	Akero Therapeutics, Inc. (AKRO)
iva337	Inventiva S.A. (IVEVF)
iva337	Inventiva S.A. (IVA)
Pegozafermin	89bio, Inc. (ETNB)
Pitolisant oral tablets	Crinetics Pharmaceuticals, Inc. (CRNX)
Resmetirom	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Vortioxetine tablets	Crinetics Pharmaceuticals, Inc. (CRNX)

Phase 2(29)

Drug	Company
ADX-629	Aldeyra Therapeutics, Inc. (ALDX)
BIO89-100	89bio, Inc. (ETNB)
BPL-003	Atai Beckley N.V. (ATAI)
cagrilintide + semaglutide	Novo Nordisk A/S (NVO)
efruxifermin	Akero Therapeutics, Inc. (AKRO)
EFX	Akero Therapeutics, Inc. (AKRO)
GSK-4532990	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
hm15211	ANI PHARMACEUTICALS INC (ANIP)
int-787	INTERCEPT PHARMACEUTICALS, INC. (ICPT)
larsucosterol	DURECT CORP (DRRX)
mazdutide	ELI LILLY & Co (LLY)
mgl-3196	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
MLR-1023	Adhera Therapeutics, Inc. (ATRX)
ngm282	NGM BIOPHARMACEUTICALS INC (NGM)
nnc0174 0833	Novo Nordisk A/S (NVO)
nnc0194 0499	Novo Nordisk A/S (NVO)
nnc0194-0499	Novo Nordisk A/S (NVO)
opnt002	OPIANT PHARMACEUTICALS, INC. (OPNT)
pemvidutide	Altimmune, Inc. (ALT)
pemvidutide (ALT-801)	Altimmune, Inc. (ALT)
pemvidutide (formerly ALT-801)	Altimmune, Inc. (ALT)
PLN-1474	PLIANT THERAPEUTICS, INC. (PLRX)
ptm cilo/fir	GILEAD SCIENCES, INC. (GILD)
ptm sema	GILEAD SCIENCES, INC. (GILD)
Rencofilstat (formerly CRV431; CPI-431-32)	Hepion Pharmaceuticals, Inc. (CTRVP)
rencofilstat (formerly CRV431)	Hepion Pharmaceuticals, Inc. (CTRVP)
seladelpar	CymaBay Therapeutics, Inc. (CBAY)
Synthroid	ENANTA PHARMACEUTICALS INC (ENTA)
tvb-2640	Sagimet Biosciences Inc. (SGMT)

Phase 1(9)

Drug	Company
ACT500 tablets	Crinetics Pharmaceuticals, Inc. (CRNX)
aramchol free acid	Galmed Pharmaceuticals Ltd. (GLMD)
ARO-HSD Injection	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
cotadutide	ASTRAZENECA PLC (AZN)
dcr-aud	Dicerna Pharmaceuticals Inc (DRNA)
hec169584	SUNSHINE BIOPHARMA INC. (SBFM)
LY3537031	ELI LILLY & Co (LLY)
miricorilant	CORCEPT THERAPEUTICS INC (CORT)
szn-043	Surrozen Inc. (SRZN)

Preclinical(4)

Drug	Company
AGTX-2003 (RTI-1092769)	Agentix Corp. (AGTX)
electroceuticals therapeutic devices	ENDONOVO THERAPEUTICS, INC. (ENDV)
jkb-122	Biostax Corp. (BTAX)
siRNA targeting Beta2-spectrin	Bullfrog AI Holdings Inc. (BFRG)

Unknown(1)

Drug	Company
legalon	Mylan II B.V. (MYL)

Early Phase 1(1)

Drug	Company
neuroinflammation	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 1/Phase 2(3)

Drug	Company
cmnd-100	Clearmind Medicine Inc. (CMND)
ft-4101	Forma Therapeutics Holdings, Inc. (FMTX)
ft-8225	Forma Therapeutics Holdings, Inc. (FMTX)

Phase 4(1)

Drug	Company
Tirzepatide	ENANTA PHARMACEUTICALS INC (ENTA)

BioSniper tracks 65 drugs in development for Alcohol across 45 companies.

There are 1 clinical trial targeting Alcohol tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.